Literature DB >> 1465621

Hepatic synthesis of lipoproteins and apolipoproteins.

J L Dixon1, H N Ginsberg.   

Abstract

We have attempted to review new information concerning the regulation of the secretion of three major apolipoproteins that are synthesized in the liver: apoB, apoA-I, and apoE. ApoB, which is a large protein involved in the transport of triglyceride and cholesterol from the liver to the peripheral tissues, appears not to be regulated on a short-term basis at the transcriptional level. Rather, once synthesized, this protein, which is unique in its intracellular transport in the secretory pathway, is subjected to post-translational regulation, which is dependent on the lipid status of the cell. Assembly of nascent apoB-containing LPs begins in the ER. If core lipids, whether triglyceride or cholesteryl ester, are limiting, then apoB will be rapidly degraded, most likely in the ER compartment. However, if one or both of the core lipids are available in adequate quantities, then apoB will be protected in the ER, and more apoB, in the form of an apoB-containing LP (whether VLDL or a smaller particle) will be secreted by the hepatocyte. Addition of surface lipids, mainly phospholipids or free cholesterol, probably occurs in the Golgi. A further mechanism that regulates the secretion of apoB-containing LPs may involve rapid reuptake of newly secreted particles. The regulation of the secretion of apoA-I by liver is very different from that of apoB. Although apoA-I is also synthesized on attached ribosomes and becomes contranslationally or post-translationally associated with the RER membrane, it is transported to the Golgi much more rapidly than apoB. In the Golgi nascent HDL particles are formed, but it is also likely that apoA-I is secreted by the hepatocyte in a lipid-poor form.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1465621     DOI: 10.1055/s-2008-1040406

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  11 in total

Review 1.  Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.

Authors:  Graziella Privitera; Luisa Spadaro; Simona Marchisello; Giuseppe Fede; Francesco Purrello
Journal:  Dig Dis Sci       Date:  2017-11-25       Impact factor: 3.199

2.  Metabolic adaptations to dietary fat malabsorption in chylomicron-deficient mice.

Authors:  H R Jung; S M Turner; R A Neese; S G Young; M K Hellerstein
Journal:  Biochem J       Date:  1999-10-15       Impact factor: 3.857

3.  Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL.

Authors:  Anny Mulya; Ji-Young Lee; Abraham K Gebre; Elena Y Boudyguina; Soon-Kyu Chung; Thomas L Smith; Perry L Colvin; Xian-Cheng Jiang; John S Parks
Journal:  J Lipid Res       Date:  2008-06-25       Impact factor: 5.922

4.  The apolipoprotein m-sphingosine-1-phosphate axis: biological relevance in lipoprotein metabolism, lipid disorders and atherosclerosis.

Authors:  Bas W C Arkensteijn; Jimmy F P Berbée; Patrick C N Rensen; Lars B Nielsen; Christina Christoffersen
Journal:  Int J Mol Sci       Date:  2013-02-25       Impact factor: 5.923

5.  Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma.

Authors:  Mario Uccello; Giulia Malaguarnera; Elisa M Pelligra; Antonio Biondi; Francesco Basile; Massimo Motta
Journal:  Indian J Med Paediatr Oncol       Date:  2011-04

6.  Hepatic overexpression of methionine sulfoxide reductase A reduces atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Yan-Yong Xu; Fen Du; Bing Meng; Guang-Hui Xie; Jia Cao; Daping Fan; Hong Yu
Journal:  J Lipid Res       Date:  2015-08-28       Impact factor: 5.922

7.  Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort.

Authors:  Kristine S Alexander; Neil A Zakai; Steven D Lidofsky; Peter W Callas; Suzanne E Judd; Russell P Tracy; Mary Cushman
Journal:  PLoS One       Date:  2018-03-12       Impact factor: 3.240

8.  Ancient RNA from Late Pleistocene permafrost and historical canids shows tissue-specific transcriptome survival.

Authors:  Oliver Smith; Glenn Dunshea; Mikkel-Holger S Sinding; Sergey Fedorov; Mietje Germonpre; Hervé Bocherens; M T P Gilbert
Journal:  PLoS Biol       Date:  2019-07-30       Impact factor: 8.029

9.  Telomere length is maternally inherited and associated with lipid metabolism in Chinese population.

Authors:  Liyun Guo; Yajuan Chen; Huiqin Li; Fanqian Yin; Mingxia Ge; Li Hu; Meiting Zi; Zhenghong Qin; Yonghan He
Journal:  Aging (Albany NY)       Date:  2022-01-07       Impact factor: 5.682

10.  A new human 3D-liver model unravels the role of galectins in liver infection by the parasite Entamoeba histolytica.

Authors:  Debora B Petropolis; Daniela M Faust; Gagan Deep Jhingan; Nancy Guillen
Journal:  PLoS Pathog       Date:  2014-09-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.